GLP-1 medications such as Ozempic and Wegovy have transformed treatment for Type 2 diabetes and obesity, but new research suggests doctors may need to pay closer attention to bone health, especially ...

A new study finds quitting GLP-1 drugs like Ozempic can reverse health gains and increase heart health risks. Patients who stopped taking the medication saw a higher risk for heart attack, stroke, or ...

People who stop taking popular weight-loss and diabetes medications may lose out on any heart health benefits the medications provided. GLP-1 receptor agonists — such as semaglutide (Ozempic and ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose. There is new evidence that drugs like Ozempic can reduce ...